Suppressed expression of calcium-binding protein regucalcin mRNA in the renal cortex of rats with chemically induced kidney damage
- 1 January 1995
- journal article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 151 (1) , 55-60
- https://doi.org/10.1007/bf01076896
Abstract
The alteration of Ca2+-binding protein regucalcin mRNA expression in the kidney cortex of rats administered cisplatin and cephaloridine, which can induce kidney damage, was investigated. Cisplatin (0.25, 0.5 and 1.0 mg/100 g body weight) or cephaloridine (25, 50 and 100 mg/100 g) was intraperitoneally administered in rats, and 1, 2 and 3 days later they were sacrificed. The alteration in serum findings after the administration of cisplatin (1.0 mg/100 g) or cephaloridine (50 and 100 mg/100 g) demonstrated chemically induced kidney damage; blood urea nitrogen (BUN) concentration increased markedly and serum inorganic phosphorus or calcium concentration decreased significantly. Moreover, the administration of cisplatin (1.0 mg/100 g) or cephaloridine (100 mg/100 g) caused a remarkable increase of calcium content in the kidney cortex of rats, indicating kidney damage. The expression of regucalcin mRNA in the kidney cortex was markedly reduced by the administration of cisplatin or cephaloridine in rats, when the mRNA levels were analyzed by Northern blotting using rat liver regucalcin cDNA (0.9 kb). The mRNA decreases were seen with the used lowest dose of cisplatin or cephaloridine. The present study clearly demonstrates that the mRNA expression of Ca2+-binding protein regucalcin in the kidney cortex of rats is decreased by chemically induced kidney damage.Keywords
This publication has 23 references indexed in Scilit:
- Molecular cloning and sequencing of the cDNA coding for a calcium‐binding protein regucalcin from rat liverFEBS Letters, 1993
- Expression of hepatic calcium‐binding protein regucalcin mRNA is mediated through Ca2+/calmodulin in rat liverFEBS Letters, 1993
- Calcium administration stimulates the expression of calcium‐binding protein regucalcin mRNA in rat liverFEBS Letters, 1992
- Inhibitory effect of calcium‐binding protein regucalcin on Ca2+‐activated DNA fragmentation in rat liver nucleiFEBS Letters, 1991
- Glutathione: Toxicological ImplicationsAnnual Review of Pharmacology and Toxicology, 1990
- Inhibitory effect of calcium-binding protein regucalcin on protein kinase C activity in rat liver cytosolBiochemical Medicine and Metabolic Biology, 1990
- Activation of hepatic microsomal Ca2+-adenosine triphosphatase by Calcium-binding protein regucalcin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- Studies and Perspectives of Protein Kinase CScience, 1986
- Role of calcium in the hormonal regulation of liver metabolismBiochimica et Biophysica Acta (BBA) - Reviews on Bioenergetics, 1981
- Determination of Calcium in Blood Serum by Atomic Absorption SpectroscopyNature, 1960